BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen SC, Liu CJ, Hu YW, Yeh CM, Hu LY, Wang YP, Hung YP, Tzeng CH, Chiou TJ, Chen TJ, Teng CJ. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. Gastric Cancer 2016;19:490-7. [PMID: 25772342 DOI: 10.1007/s10120-015-0482-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Hemminki K. Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer. Clin Epidemiol 2021;13:515-25. [PMID: 34239328 DOI: 10.2147/CLEP.S304332] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Morais S, Antunes L, Bento MJ, Lunet N. Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal. Cancer Epidemiol 2017;50:85-91. [PMID: 28843176 DOI: 10.1016/j.canep.2017.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
3 Morais S, Castro C, Antunes L, Peleteiro B, Bento MJ, Lunet N. Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles. Eur J Cancer Prev 2019;28:159-66. [PMID: 29668653 DOI: 10.1097/CEJ.0000000000000447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Park JY. [Second Primary Cancer after Treating Gastrointestinal Cancer]. Korean J Gastroenterol 2019;74:193-6. [PMID: 31650794 DOI: 10.4166/kjg.2019.74.4.193] [Reference Citation Analysis]
5 Zheng X, Li X, Wang M, Shen J, Sisti G, He Z, Huang J, Li YM, Wu A; Multidisciplinary Oncology Research Collaborative Group (MORCG). Second primary malignancies among cancer patients. Ann Transl Med 2020;8:638. [PMID: 32566575 DOI: 10.21037/atm-20-2059] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Tseng CH. The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature. Biomolecules 2021;11:1022. [PMID: 34356646 DOI: 10.3390/biom11071022] [Reference Citation Analysis]
7 Min SK, Choi SW, Lim J, Park JY, Jung KW, Won YJ. Second primary cancers in patients with oral cavity cancer included in the Korea Central Cancer Registry. Oral Oncol 2019;95:16-28. [PMID: 31345385 DOI: 10.1016/j.oraloncology.2019.05.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Huang X, Qian J, Li L, Zhang X, Wei G, Lv J, Qin F, Yu J, Xiao Y, Gong Z, Huo J. Curcumol improves cisplatin sensitivity of human gastric cancer cells through inhibiting PI3K/AKT pathway. Drug Dev Res 2020. [PMID: 32715509 DOI: 10.1002/ddr.21719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Halamkova J, Kazda T, Pehalova L, Gonec R, Kozakova S, Bohovicova L, Krakorova DA, Slaby O, Demlova R, Svoboda M, Kiss I. Second primary malignancies in colorectal cancer patients. Sci Rep 2021;11:2759. [PMID: 33531585 DOI: 10.1038/s41598-021-82248-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Tay ZY, Kao HK, Lien KH, Hung SY, Huang Y, Tsang NM, Chang KP. The impact of preoperative glycated hemoglobin levels on outcomes in oral squamous cell carcinoma. Oral Dis 2020;26:1449-58. [PMID: 32426892 DOI: 10.1111/odi.13433] [Reference Citation Analysis]
11 Morais S, Antunes L, Bento MJ, Lunet N. The effect of a gastric second primary cancer on the survival of patients with a previous cancer history. Eur J Cancer Prev 2020;29:215-21. [PMID: 31651567 DOI: 10.1097/CEJ.0000000000000540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]